Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
- PMID: 21849044
- PMCID: PMC3175443
- DOI: 10.1186/1746-160X-7-16
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Abstract
Purpose: Bisphosphonate - related osteonecrosis of the JAW (BRONJ) is a well known side effect of bisphosphonate therapies in oncologic and non oncologic patients. Since to date no definitive consensus has been reached on the treatment of BRONJ, novel strategies for the prevention, risk reduction and treatment need to be developed. We report a 75 year old woman with stage 3 BRONJ secondary to alendronate and pamidronate treatment of osteoporosis. The patient was unresponsive to recommended treatment of the disease, and her BRONJ was worsening. Since bone marrow stem cells are know as being multipotent and exhibit the potential for differentiation into different cells/tissue lineages, including cartilage, bone and other tissue, we performed autologous bone marrow stem cell transplantation into the BRONJ lesion of the patient.
Methods: Under local anesthesia a volume of 75 ml of bone marrow were harvested from the posterior superior iliac crest by aspiration into heparinized siringes. The cell suspension was concentrated, using Ficoll - Hypaque® centrifugation procedures, in a final volume of 6 ml. Before the injection of stem cells into the osteonecrosis, the patient underwent surgical toilet, local anesthesia was done and spongostan was applied as a carrier of stem cells suspension in the bone cavity, then 4 ml of stem cells suspension and 1 ml of patient's activated platelet-rich plasma were injected in the lesion of BRONJ.
Results: A week later the residual spongostan was removed and two weeks later resolution of symptoms was obtained. Then the lesion improved with progressive superficialization of the mucosal layer and CT scan, performed 15 months later, shows improvement also of bone via concentric ossification: so complete healing of BRONJ (stage 0) was obtained in our patient, and 30 months later the patient is well and without signs of BRONJ.
Conclusion: To our knowledge this is the first case of BRONJ successfully treated with autologous stem cells transplantation with a complete response.
Figures





Similar articles
-
The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006. J Oral Maxillofac Surg. 2009. PMID: 19371819
-
Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap.Oral Oncol. 2011 May;47(5):425-9. doi: 10.1016/j.oraloncology.2011.03.022. Epub 2011 Apr 7. Oral Oncol. 2011. PMID: 21478047
-
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.J Oral Maxillofac Surg. 2011 Jan;69(1):84-91. doi: 10.1016/j.joms.2010.07.014. Epub 2010 Oct 25. J Oral Maxillofac Surg. 2011. PMID: 20971542
-
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13. Minerva Stomatol. 2010. PMID: 20360666 Review. English, Italian.
-
Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.Head Neck Pathol. 2007 Dec;1(2):132-40. doi: 10.1007/s12105-007-0033-2. Epub 2007 Dec 5. Head Neck Pathol. 2007. PMID: 20614264 Free PMC article. Review.
Cited by
-
Mesenchymal stem cells in the treatment of osteonecrosis of the jaw.J Korean Assoc Oral Maxillofac Surg. 2021 Apr 30;47(2):65-75. doi: 10.5125/jkaoms.2021.47.2.65. J Korean Assoc Oral Maxillofac Surg. 2021. PMID: 33911038 Free PMC article. Review.
-
Bisphosphonate-related osteonecrosis of jaws in advanced stage breast cancer was detected from bone scan: a case report.Gland Surg. 2017 Feb;6(1):93-100. doi: 10.21037/gs.2016.07.04. Gland Surg. 2017. PMID: 28210558 Free PMC article.
-
Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication-Related Osteonecrosis of the Jaw in a Rat Model.JBMR Plus. 2017 Sep 6;2(2):69-80. doi: 10.1002/jbm4.10013. eCollection 2018 Mar. JBMR Plus. 2017. PMID: 30283893 Free PMC article.
-
Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration.Front Cell Dev Biol. 2021 May 13;9:674084. doi: 10.3389/fcell.2021.674084. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34079804 Free PMC article. Review.
-
Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.Oral Maxillofac Surg. 2016 Mar;20(1):9-17. doi: 10.1007/s10006-015-0538-x. Epub 2015 Dec 11. Oral Maxillofac Surg. 2016. PMID: 26659615 Review.
References
-
- McClug MR. Bisphosphonates. Endocrinol Metab Clin North Am. 2003;32 253 71. - PubMed
-
- Boissier S, Magnetto S, Frappart L, Cuzin B, Ebetino FH, Delmas PD. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res. 1997;57:3890–3894. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical